Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: Early discrimination between survival and death

Acetaminophen (APAP) is the leading cause of acute liver injury in the developed world. Timely administration of N‐acetylcysteine (N‐Ac) prevents the progression of serious liver injury and disease, whereas failure to administer N‐Ac within a critical time frame allows disease progression and in the...

Full description

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 56; no. 2; pp. 727 - 734
Main Authors Remien, Christopher H., Adler, Frederick R., Waddoups, Lindsey, Box, Terry D., Sussman, Norman L.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.08.2012
Wiley
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acetaminophen (APAP) is the leading cause of acute liver injury in the developed world. Timely administration of N‐acetylcysteine (N‐Ac) prevents the progression of serious liver injury and disease, whereas failure to administer N‐Ac within a critical time frame allows disease progression and in the most severe cases may result in liver failure or death. In this situation, liver transplantation may be the only life‐saving measure. Thus, the outcome of an APAP overdose depends on the size of the overdose and the time to first administration of N‐Ac. We developed a system of differential equations to describe acute liver injury due to APAP overdose. The Model for Acetaminophen‐induced Liver Damage (MALD) uses a patient's aspartate aminotransferase (AST), alanine aminotransferase (ALT), and international normalized ratio (INR) measurements on admission to estimate overdose amount, time elapsed since overdose, and outcome. The mathematical model was then tested on 53 patients from the University of Utah. With the addition of serum creatinine, eventual death was predicted with 100% sensitivity, 91% specificity, 67% positive predictive value (PPV), and 100% negative predictive value (NPV) in this retrospective study. Using only initial AST, ALT, and INR measurements, the model accurately predicted subsequent laboratory values for the majority of individual patients. This is the first dynamical rather than statistical approach to determine poor prognosis in patients with life‐threatening liver disease due to APAP overdose. Conclusion: MALD provides a method to estimate overdose amount, time elapsed since overdose, and outcome from patient laboratory values commonly available on admission in cases of acute liver failure due to APAP overdose and should be validated in multicenter prospective evaluation. (HEPATOLOGY 2012)
Bibliography:ark:/67375/WNG-3670RL52-X
ArticleID:HEP25656
Potential conflict of interest: Dr. Sussman owns stock in, is an employee of, and consults for HepaHope.
istex:D6C5776BAF657F33562EA1F3AC3AAE2806E96DDF
fax: 801‐581‐4148
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0270-9139
1527-3350
DOI:10.1002/hep.25656